Monocyte recruitment and neointimal hyperplasia in rabbits: Coupled inhibitory effects of heparin

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 10, 1996, Pages 1312-1318

  Rogers, Campbell ^a,c   Welt, Frederick G P ^a   Karnovsky, Morris J ^b   Edelman, Elazer R ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

heparin; monocytes; restenosis; stent

Indexed keywords

HEPARIN;

ANIMAL EXPERIMENT; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD CLOT LYSIS; CELL ADHESION; CELL PROLIFERATION; DRUG EFFECT; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0029840003     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.10.1312     Document Type: Article

References (73)

1. Clowes AW, Karnovsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature (London). 1977;265:625-626.
2. Guyton JR, Rosenberg RD, Clowes AW, Karnovsky MJ. Inhibition of rat arterial smooth muscle cell proliferation by heparin: in vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res. 1980;46:625-634.
3. Cohen S, Benacerraf B, McLuskey R, Ovary A. Effect of anticoagulants on delayed hypersensitivity reactions. J Immunol. 1967;98:351-358.
4. Lider O, Mekori YA, Miller T, Bar-Tana R, Vlodavsky I, Baharav E, Cohen IR, Naparstek Y. Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity. Ear J Immunol. 1990;20:493-499.
5. Sy MS, Schneeberger E, McClusky R, Greene MI, Rosenberg RD, Benacerraf B. Inhibition of delayed-type hypersensitivity by heparin depleted of anticoagulant activity. Cell Immunol. 1983;82:23-32.
6. Ley K, Cerrito M, Arfors K-E. Sulfated polysaccharides inhibit leukocyte rolling in rabbit mesenteric venules. Am J Physiol. 1991;260:H1667-H1673.
7. Duff GL, McMillan GC, Ritchie AC. The morphology of early atherosclerotic lesions of the aorta demonstrated by the surface technique in rabbits fed cholesterol. Am J Pathol. 1957;33:845-873.
8. Leibovich SJ, Ross R. The role of the macrophage in wound repair. Am J Pathol. 1975;78:71-100.
9. Gerrity RG. The role of the monocyte in atherogenesis. Am J Pathol. 1981;103:181-190.
10. Trillo AA. The cell population of aortic fatty streaks in African green monkeys with special reference to granulocytic cells. Atherosclerosis. 1982;43:259-275.
11. Joris I, Zand T, Nunnari JJ, Krolikowski FJ, Majno G. Studies in the pathogenesis of atherosclerosis, I: adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. Am J Pathol. 1983;113:341-358.
12. Jerome WG, Lewis JC. Early atherogenesis in white carneau pigeons. Am J Pathol. 1984;116:56-68.
13. Watanabe T, Hirata M, Yoshikawa Y, Nagafuchi Y, Toyosha H, Watanabe T. Role of macrophages in atherosclerosis. Lab Invest. 1985;53:80-90.
14. Rogers K, Karnovsky MJ. A rapid method for the detection of early stages of atherosclerotic lesion formation. Am J Pathol. 1988;133:451-455.
15. Saphir O, Gore I. Evidence for an inflammatory basis of coronary arteriosclerosis in the young. Arch Pathol. 1950;49:418-426.
16. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131-138.
17. Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation. 1995;91:2995-3001.
18. Rogers C, Karnovsky MJ, Edelman ER. Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. Circulation. 1993;88:1215-1221.
19. Hanke H, Hassenstein S, Kamenz J, Oberhoff M, Baumbach A, Betz E, Karsch KR. Experimental intravascular stenting: proliferative response of smooth muscle cells. Circulation. 1991;84(suppl II)II-71. Abstract.
20. Hanke H, Hassenstein S, Kamenz J, Oberhoff M, Baumbach A, Betz E, Karsch KR. Prolonged proliferative response of smooth muscle cells after experimental intravascular stenting: a stent wire related phenomenon. Circulation. 1992;86(suppl I):I-186. Abstract.
21. Kamenz J, Hanke H, Hassenstein S, Oberhoff M, Ulmer A, Baumbach A, Betz E. Time course of accumulation of macrophages and intimal cell proliferation following experimental stenting. Circulation. 1993;88(suppl I):I-652. Abstract.
22. van Beusekom HMM, van der Giessen WJ, van Suylen RJ, Bos E, Bosnian FT, Serruys PW. Histology after stenting of human saphenous vein bypass grafts: observations from surgically excised grafts 3 to 320 days after stent implantation. J Am Coll Cardiol. 1993;21:45-54.
23. Edelman ER, Adams DH, Karnovsky MJ. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci U S A. 1990;87:3773-3777.
24. Wolf E, Roser K, Hahn M, Welkerling H, Delling G. Enzyme and immunohistochemistry on undecalcified bone and bone marrow biopsies after embedding in plastic: a new embedding method for routine application. Virchows Arch Pathol Anat. 1992;420:17-24.
25. Tsukada T, Rosenfeld M, Ross R, Gown AM. Immunocytochemical analysis of cellular components in atherosclerotic lesions: use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis. 1986;6:601-613.
26. Edelman ER, Nugent MA, Smith LT, Karnovsky MJ. Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J Clin Invest. 1992;89:465-473.
27. Schwartz RS, Holmes DH, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol. 1992;20:1284-1293.
28. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis and proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol. 1992;19:267-274.
29. Carter AJ, Laird JR, Farb A, Kufs W, Wortham DC, Virmani R. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol. 1994;24:1398-1405.
30. Pietersma A, Kofflard M, de Wit LEA, Stinjen T, Koster JF, Serruys P, Sluiter W. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation. 1995;91:1320-1325.
31. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: a multistep paradigm. Cell. 1994;76:301-314.
32. Hansson GK, Björnheden T, Bylock A, Bondjers G. Fe-dependent binding of monocytes to areas with endothelial injury in the rabbit aorta. Exp Mol Pathol. 1981;34:264-280.
33. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251:788-791.
34. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest. 1985;76:2003-2011.
35. Valente AJ, Graves DT, Vialle-Valentin CE, Delgado R, Schwartz CJ. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry. 1988;27:4162-4168.
36. Mazzone T, Jensen M, Chait A. Human arterial wall cells secrete factors that are chemotactic for monocytes. Proc Natl Acad Sci U S A. 1983;80:5094-5097.
37. Jauchem JR, Lopez M, Sprague EA, Schwartz CJ. Mononuclear cell chemoattractant activity from cultured arterial smooth muscle cells. Exp Mol Pathol 1982;37:166-174.
38. Berliner JA, Territo M, Almada L, Carter A. Shafonsky E, Fogelman AM. Monocyte chemotactic factor produced by large vessel endothelial cells in vitro. Arteriosclerosis. 1986;6:254-258.
39. Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Arteriosclerosis. 1985;5:293-302.
40. Leibovich SJ, Ross R. A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol. 1976;84:501-514.
41. Glenn KC, Ross R. Human monocyte-derived growth factor(s) for mesenchymal cells: activation of secretion by endotoxin and concanavalin A. Cell. 1981;25:603-615.
42. Martin BM, Gimbrone MA Jr. Unanue ER, Cotran RS. Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. J Immunol. 1981;126:1510-1515.
43. Martinet Y, Bitterman PB, Mornex J-F, Grotendorst GR, Martin GR, Crystal RG. Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Nature. 1986;319:158-160.
44. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A. 1987;84:6020-6024.
45. Carpenter KLH, Brabbs CE, Mitchincon MJ. Oxygen radicals and atherosclerosis. Klin Wochenschr. 1991;69:1039-1045.
46. Peri G, Chiaffarino F, Bernasconi S, Padura I, Mantovani A. Cytotoxicity of activated monocytes on endothelial cells. J Immunol. 1990;144:1444-1448.
47. Garbisa S, Ballin M, Daga-gordini D, Fastelli G, Naturale M, Negro A, Semenzato G, Liotta LA. Transient expression of type IV collagenolytic metalloproteinase produced by human mononuclear phagocytes. J Biol Chem. 1986;261:2369-2375.
48. Campbell EJ, Silverman EK, Campbell MA. Elastase and cathepsin G of human monocytes: quantification of cellular content, release in response to stimuli and heterogeneity in elastase-mediated proteolytic activity. J Immunol. 1989;143:2961-2968.
49. Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Vergilio J-A. Nicholson AC. Macrophage and foam cell release of matrix-bound growth factors: role of plasminogen activation. J Biol Chem. 1993;268:11951-11958.
50. Sewell RF, Brenchley PEC, Mallick NP, Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate. Biochem J. 1989;264:777-783.
51. Hoover RL, Folger R, Haering WA, Ware BR, Karnovsky MJ. Adhesion of leukocytes to endothelium: roles of divalent cations, surface charge, chemotactic agents and substrate. J Cell Sci. 1980;45:73-86.
52. Castellot JJ Jr, Cochran DL, Karnovsky MJ. Effect of heparin on vascular smooth muscle cells, I: cell metabolism. J Cell Physiol. 1985;124:21-28.
53. 1, phase of the cell cycle. J Biol Chem. 1989;264:6990-6995.
54. Pukac LA, Castellot JJ Jr, Wright TCJ, Caleb BL, Karnovsky MJ. Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regulation. 1990;1:435-443.
55. Castellot JJ Jr, Addonizio ML, Rosenberg RD, Karnovsky MJ. Cultured endothelial cells produce a heparin-like inhibition of smooth muscle growth. J Cell Biol. 1981;90:372-379.
56. Fritze L, Reilly C, Rosenberg R. An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells. J Cell Biol. 1985;100:1041-1049.
57. Norgard-Sumnicht KE, Varki NM, Varki A. Calcium-dependent heparin-like ligands for L-selectin in nonlymphoid endothelial cells. Science. 1993;261:480-483.
58. Tanaka Y. Adams DH, Hubscher S. Hirano H, Siebenlist U, Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1B. Nature. 1993;361:79-82.
59. Tanaka Y, Adams DH, Shaw S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today. 1993;14:111-114.
60. Skinner MP, Lucas CM, Burns GF, Chesterman CN, Berndt MC. GMP-140 binding to neutrophils is inhibited by sulfated glycans. J Biol Chem. 1991;266:5371-5374.
61. Deuel TF, Senior RM, Chang D, Griffin GL, Heinrikson RL, Kaiser ET. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A. 1981;78:4584-4587.
62. Wang JM, Sherry N, Fivash MJ, Kelvin DJ, Oppenheim JJ. Human recombinant macrophage inflammatory protein-1α and -β and monocyte chemotactic and activating factor utilize unique receptors on human monocytes. J Immunol. 1993;150:3022-3029.
63. Gensini GF, Fortini A, Lombardi A, Pesciullesi E, Pieroni C, Neri Serneri GG. Binding of low-molecular-weight heparin to aortic endothelium in rabbits. Haemostasis. 1984;14:466-472.
64. Fraser I, Hughes D, Gordon S. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine sea venger receptor. Nature. 1993;364:343-346.
65. Nusrat AR, Chapman HA. An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J Clin Invest. 1991;87:1091-1097.
66. Waltz DA, Sailor LZ, Chapman HA. Cytokines induce urokinase-dependent adhesion of human myeloid cells: a regulatory role for plasminogen activator inhibitors. J Clin Invest. 1993;91:1541-1552.
67. Waltz DA, Chapman HA. Reversible cellular adhesion to vitronectin linked to receptor occupancy. J Biol Chem. 1994;269:14746-14750.
68. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem. 1994;269:32380-32388.
69. Preissner KT, Muller-Berhaus G. Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. J Biol Chem. 1987;262:12247-12253.
70. Flaumenhaft R, Abe M, Mignatti P, Rifkin DB. Basic fibroblast growth factor-induced activation of latent TGF-β in endothelial cells: regulation of plasminogen activator activity. J Cell Biol. 1992;118:901-909.
71. Mignatti P, Mazzieri R, Rifkin DB. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J Cell Biol. 1991;113:1193-1201.
72. Hamilton JA, Piccoli T, Leizer DM, Butler M, Croatto M, Royston AKM. Transforming growth factor β stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts. Proc Natl Acad Sci U S A. 1991;88:7180-7184.
73. Appella E, Robinson SJ. Ullrich MP, Stoppelli A, Corti A, Cassani G, Blasi F. The receptor-binding sequence of urokinase: a biological function for the growth-factor module of proteases. J Biol Chem. 1987;262:4437-4440.